<?xml version="1.0" encoding="UTF-8"?>
<ref id="B59-vaccines-07-00074">
 <label>59.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kong</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>J.H.</given-names>
   </name>
   <name>
    <surname>Doores</surname>
    <given-names>K.J.</given-names>
   </name>
   <name>
    <surname>Murin</surname>
    <given-names>C.D.</given-names>
   </name>
   <name>
    <surname>Julien</surname>
    <given-names>J.-P.</given-names>
   </name>
   <name>
    <surname>McBride</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Marozsan</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Cupo</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Klasse</surname>
    <given-names>P.J.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120</article-title>
  <source>Nat. Struct. Mol. Biol.</source>
  <year>2013</year>
  <volume>20</volume>
  <fpage>796</fpage>
  <lpage>803</lpage>
  <pub-id pub-id-type="doi">10.1038/nsmb.2594</pub-id>
  <pub-id pub-id-type="pmid">23708606</pub-id>
 </element-citation>
</ref>
